Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Zelin HouYu PanQinglin FeiYali LinYuanyuan ZhouYing LiuHongdan GuanXunbin YuXianchao LinFengchun LuHeguang HuangPublished in: Journal of cancer research and clinical oncology (2020)
VISTA expressed in TCs is associated with a favorable prognosis in PDAC. Moreover, immunotherapy with anti-VISTA antibodies may potentially be an effective treatment strategy against PDAC.
Keyphrases